The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial

被引：0
|
作者：
Krithika Rajagopalan
Elizabeth Dansie Bacci
Kathleen W. Wyrwich
Andrei Pikalov
Antony Loebel
机构：
[1] Sunovion Pharmaceuticals Inc.,
[2] Evidera,undefined
[3] Sunovion Pharmaceuticals Inc.,undefined
[4] Evidera,undefined
来源：
International Journal of Bipolar Disorders | / 4卷
关键词：
Sheehan disability scale; Patient functioning; Bipolar disorder; Depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    Brown, E. Sherwood
    Park, John
    Marx, Christine E.
    Hynan, Linda S.
    Gardner, Claire
    Davila, Domingo
    Nakamura, Alyson
    Sunderajan, Prabha
    Lo, Alexander
    Holmes, Traci
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (12) : 2867 - 2873
  • [32] Quetiapine monotherapy improves anxiety symptoms in bipolar depression: Results from two randomized, double-blind placebo-controlled studies
    Lydiard, R. Bruce
    Macfadden, Wayne
    Raines, Shane
    Culpepper, Larry A.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S227 - S228
  • [33] Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
    Singh, Manpreet K.
    Pikalov, Andrei
    Siu, Cynthia
    Tocco, Michael
    Loebel, Antony
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (10) : 590 - 598
  • [34] LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION ASSOCIATED WITH MIXED (SUBSYNDROMAL HYPOMANIC) FEATURES: POST HOC ANALYSIS OF A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Pikalov, Andrei A.
    Siu, Cynthia
    Tocco, Michael
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S169 - S169
  • [35] Safety and tolerability of lurasidone in acute exacerbation of bipolar depression: Systematic review and meta-analysis of lurasidone randomized placebo-controlled trials
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    Loebel, A.
    BIPOLAR DISORDERS, 2019, 21 : 128 - 128
  • [36] Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts
    Suppes, Trisha
    Kroger, Hans
    Pikalov, Andrei
    Loebel, Antony
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 78 : 86 - 93
  • [37] Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia
    Loebel, Antony D.
    Siu, Cynthia O.
    Cucchiaro, Josephine B.
    Pikalov, Andrei A.
    Harvey, Philip D.
    CNS SPECTRUMS, 2014, 19 (02) : 197 - 205
  • [38] Efficacy of cariprazine in patients with bipolar depression: Results from 3 randomized, double-blind, placebo-controlled trials
    Earley, W.
    Burgess, M.
    Rekeda, L.
    McIntyre, R. S.
    Sachs, G. S.
    Yatham, L. N.
    Suppes, T.
    Tohen, M.
    Calabrese, J.
    Vieta, E.
    BIPOLAR DISORDERS, 2019, 21 : 137 - 137
  • [39] Levetiracetam in the Management of Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Saricicek, Aybala
    Maloney, Kathleen
    Muralidharan, Anjana
    Ruf, Barbara
    Blumberg, Hilary P.
    Sanacora, Gerard
    Lorberg, Boris
    Pittman, Brian
    Bhagwagar, Zubin
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (06) : 744 - 750
  • [40] Lurasidone in children and adolescents with bipolar depression associated with mixed (Subsyndromal Hypomanic) features: post-hoc analysis of a randomized placebo-controlled trial
    Tocco, M.
    Pikalov, A.
    Siu, C.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 67
12345